Published in J Mol Cell Cardiol on July 01, 1994
The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5' nontranslated region. J Virol (1995) 1.64
Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway. J Virol (2002) 1.53
The role of infections in autoimmune disease. Clin Exp Immunol (2009) 1.47
Coxsackievirus B3-induced myocarditis: perforin exacerbates disease, but plays no detectable role in virus clearance. Am J Pathol (1998) 1.46
Reovirus induction of and sensitivity to beta interferon in cardiac myocyte cultures correlate with induction of myocarditis and are determined by viral core proteins. J Virol (1998) 1.23
Basal expression levels of IFNAR and Jak-STAT components are determinants of cell-type-specific differences in cardiac antiviral responses. J Virol (2007) 1.18
Reovirus-induced acute myocarditis in mice correlates with viral RNA synthesis rather than generation of infectious virus in cardiac myocytes. J Virol (1996) 1.10
Viral persistence and chronic immunopathology in the adult central nervous system following Coxsackievirus infection during the neonatal period. J Virol (2009) 1.10
Basal and reovirus-induced beta interferon (IFN-beta) and IFN-beta-stimulated gene expression are cell type specific in the cardiac protective response. J Virol (2005) 1.01
Interferon regulatory factor 3 is required for viral induction of beta interferon in primary cardiac myocyte cultures. J Virol (1999) 0.96
Viral myocarditis: from experimental models to molecular diagnosis in patients. Heart Fail Rev (2013) 0.91
In vivo ablation of type I interferon receptor from cardiomyocytes delays coxsackieviral clearance and accelerates myocardial disease. J Virol (2014) 0.86
Ganciclovir and cidofovir treatment of cytomegalovirus-induced myocarditis in mice. Antimicrob Agents Chemother (2001) 0.84
Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives. Heart Fail Rev (2013) 0.80
Death waits for no man--does it wait for a virus? How enteroviruses induce and control cell death. Cytokine Growth Factor Rev (2014) 0.79
Recurrent pericarditis in children: elevated cardiac autoantibodies. Clin Res Cardiol (2006) 0.78
eHEART: www.heartjnl.com. Heart (2000) 0.75
Coxsackievirus B escapes the infected cell in ejected mitophagosomes. J Virol (2017) 0.75
Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation (1996) 9.00
Safety of transesophageal echocardiography. A multicenter survey of 10,419 examinations. Circulation (1991) 3.70
Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation. J Bone Miner Res (1996) 2.86
Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine. Nat Genet (1998) 2.77
Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy. Eur Heart J (1999) 2.24
Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells. Exp Cell Res (1999) 2.06
Investigation on radiofrequency and laser (980 nm) effects after endoluminal treatment of saphenous vein insufficiency in an ex-vivo model. Eur J Vasc Endovasc Surg (2006) 1.99
Identification of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate as a major activator for human gammadelta T cells in Escherichia coli. FEBS Lett (2001) 1.96
NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel. Br J Cancer (2005) 1.87
Role of 1 alpha,25-dihydroxyvitamin D3 in osteoclast differentiation and function. Methods Enzymol (1997) 1.81
Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo. Kidney Int (2000) 1.81
PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase. J Clin Invest (1998) 1.74
Health-related quality of life after radical cystectomy for bladder cancer: a comparison of ileal conduit and orthotopic bladder replacement. BJU Int (2002) 1.69
Interactions between pacemakers and security systems. Pacing Clin Electrophysiol (1998) 1.68
Expression of novel DNA-binding protein with zinc finger structure in various tumor cells. J Biol Chem (1990) 1.61
Outbreak of infantile gastroenteritis due to type 40 adenovirus. Lancet (1983) 1.55
Regulation of osteoclast function. J Bone Miner Res (1997) 1.55
Modulation of osteoclast differentiation by local factors. Bone (1995) 1.47
Demonstration of organ specific antibodies against heart mitochondria (anti-M7) in sera from patients with some forms of heart diseases. Clin Exp Immunol (1984) 1.46
Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo. Kidney Int (2000) 1.44
Translocation t(16;21) in acute nonlymphocytic leukemia with abnormal eosinophils. Cancer Genet Cytogenet (1988) 1.42
Progressive dysphasic dementia with localized cerebral atrophy: report of an autopsy. Clin Neuropathol (1991) 1.41
Characterization of a human monoclonal antibody with broad reactivity to malignant tumor cells. J Natl Cancer Inst (1988) 1.41
Beneficial effects of interferon-alpha in a case with Behçet's disease. Intern Med (2000) 1.40
Alcohol and rhythm disturbance: the holiday heart syndrome. Herz (1996) 1.40
Clinical and virological features of chronic hepatitis C carriers with normal alanine aminotransferase levels despite positive serum HCV-RNA after interferon therapy. J Gastroenterol (1999) 1.39
Activation of NF-kappaB is involved in the survival of osteoclasts promoted by interleukin-1. J Biol Chem (1998) 1.38
[Complicated course of Churg-Strauss syndrome with eosinophilic perimyocarditis and pericardial tamponade]. Dtsch Med Wochenschr (2004) 1.38
HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein. Hepatology (1993) 1.36
Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. Am J Cardiol (1983) 1.35
Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS). Circulation (1997) 1.34
Neurons, intracellular and extracellular neurofibrillary tangles in subdivisions of the hippocampal cortex in normal ageing and Alzheimer's disease. Neurosci Lett (1995) 1.28
LytB, a novel gene of the 2-C-methyl-D-erythritol 4-phosphate pathway of isoprenoid biosynthesis in Escherichia coli. FEBS Lett (2001) 1.27
Analysis of Clostridium difficile isolates from nosocomial outbreaks at three hospitals in diverse areas of Japan. J Clin Microbiol (2001) 1.26
Clinical significance of immunopathological findings in patients with post-pericardiotomy syndrome. I. Relevance of antibody pattern. Clin Exp Immunol (1979) 1.25
Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases. Rheumatology (Oxford) (2006) 1.24
Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis. Clin Exp Immunol (1982) 1.23
Integrins and signaling in osteoclast function. Matrix Biol (2000) 1.21
GcpE is involved in the 2-C-methyl-D-erythritol 4-phosphate pathway of isoprenoid biosynthesis in Escherichia coli. J Bacteriol (2001) 1.21
Diaryl ester prodrugs of FR900098 with improved in vivo antimalarial activity. Bioorg Med Chem Lett (2001) 1.18
A neurofibromatosis type 1 patient with severe kyphoscoliosis and intrathoracic meningocele. J Clin Neurosci (2003) 1.17
The plastid-like organelle of apicomplexan parasites as drug target. Curr Pharm Des (2008) 1.17
The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). First epidemiological results. Herz (2000) 1.14
Oncogenic potential of hepatitis B virus. Mol Biol Med (1989) 1.13
Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact. Endocrinology (1996) 1.12
Reversal of tachycardia induced cardiomyopathy following ablation of repetitive monomorphic right ventricular outflow tract tachycardia. Pacing Clin Electrophysiol (2001) 1.11
Cardiotoxicity of 5-fluorouracil. Cardiovasc Hematol Agents Med Chem (2006) 1.11
QT dispersion and arrhythmic events in idiopathic dilated cardiomyopathy. Am J Cardiol (1996) 1.11
The small GTP-binding protein, rho p21, is involved in bone resorption by regulating cytoskeletal organization in osteoclasts. J Cell Sci (1995) 1.10
Stable association of PYK2 and p130(Cas) in osteoclasts and their co-localization in the sealing zone. J Biol Chem (1999) 1.08
Autoimmunity against the second extracellular loop of beta(1)-adrenergic receptors induces beta-adrenergic receptor desensitization and myocardial hypertrophy in vivo. Circ Res (2001) 1.07
Inhibition of osteoclast function by adenovirus expressing antisense protein-tyrosine kinase 2. J Biol Chem (2000) 1.07
Complications of third-generation implantable cardioverter defibrillator therapy. Pacing Clin Electrophysiol (1999) 1.06
Tools for discovery of inhibitors of the 1-deoxy-D-xylulose 5-phosphate (DXP) synthase and DXP reductoisomerase: an approach with enzymes from the pathogenic bacterium Pseudomonas aeruginosa. FEMS Microbiol Lett (2000) 1.05
Electrophysiologic evaluation of sinus node function and atrioventricular conduction in patients with prolonged ventricular asystole during obstructive sleep apnea. Am J Cardiol (1996) 1.05
Abnormal localisation and hyperclustering of (alpha)(V)(beta)(3) integrins and associated proteins in Src-deficient or tyrphostin A9-treated osteoclasts. J Cell Sci (2001) 1.05
Cutting edge: human gamma delta T cells are activated by intermediates of the 2-C-methyl-D-erythritol 4-phosphate pathway of isoprenoid biosynthesis. J Immunol (2001) 1.04
Hepatitis B core antigen stimulates interleukin-10 secretion by both T cells and monocytes from peripheral blood of patients with chronic hepatitis B virus infection. Clin Exp Immunol (2004) 1.04
The renin-angiotensin-aldosterone system and myocardial collagen matrix remodelling in congestive heart failure. Eur Heart J (1995) 1.03
Generation of F1 hybrid cytotoxic T lymphocytes specific for self H-2. Nature (1981) 1.02
Three new cytotoxic T cell epitopes identified within the hepatitis C virus nucleoprotein. J Gen Virol (1996) 1.01
Outcome of patients with sleep apnea-associated severe bradyarrhythmias after continuous positive airway pressure therapy. Am J Cardiol (2000) 1.00
Calcitonin-induced changes in the cytoskeleton are mediated by a signal pathway associated with protein kinase A in osteoclasts. Endocrinology (1996) 1.00
The use of local anaesthetic microinjections to identify central pathways: a quantitative evaluation of the time course and extent of the neuronal block. Exp Brain Res (1987) 1.00
Hematopoietic histoincompatibility reactions by NK cells in vitro: model for genetic resistance to marrow grafts. Science (1985) 0.99
Immobilized anhydrotrypsin as a specific affinity adsorbent for tryptic peptides. Methods Enzymol (1983) 0.98
Giant left atrial mass in an asymptomatic patient. Heart (2004) 0.97
DNA replication as a prerequisite for the induction of primary antibody response. Cell Immunol (1972) 0.97
[Malignant angiosarcoma of the right atrium in pregnancy. Diagnostic and therapeutic problems]. Herz (1994) 0.96
Requirement of parental T lymphocytes for the in vitro induction of F1 hybrid anti-parent cytotoxicity. Eur J Immunol (1979) 0.96
[[1]Benzothieno[3,2-b]pyridin-4-yl-amine--synthesis and investigation of activity against malaria]. Pharmazie (2004) 0.96
Transthyretin Leu 68 in a form of cardiac amyloidosis. Basic Res Cardiol (1992) 0.96
Structure-activity relationships of novel anti-malarial agents. Part 2: cinnamic acid derivatives. Bioorg Med Chem Lett (2001) 0.95
[Accidental decrease in the air flow during air/oxygen sevoflurane anesthesia]. Masui (2000) 0.95
Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia. Haematologica (2000) 0.95
Sigmoid neobladder in women after radical cystectomy. J Urol (2000) 0.95
Syncope recurrence can better be predicted by history than by head-up tilt testing in untreated patients with suspected neurally mediated syncope. Eur Heart J (1997) 0.95
Hormonal regulation of cardiac fibroblast function. Eur Heart J (1995) 0.94
[Cardiac rehabilitation--more than just for the garden plot?]. Herz (2012) 0.94
Genetic control of the natural killer cell activity in SJL and other strains of mice. J Immunol (1985) 0.94
Natural resistance of lethally irradiated F1 hybrid mice to parental marrow grafts is a function of H-2/Hh-restricted effectors. J Exp Med (1984) 0.94
Influence of D-net (European GSM-Standard) cellular phones on pacemaker function in 50 patients with permanent pacemakers. Pacing Clin Electrophysiol (1996) 0.94
Endomyocardial biopsy in infants and children: experience in 60 patients. Pediatr Cardiol (1990) 0.93
Mapping of a gene responsible for twy (tip-toe walking Yoshimura), a mouse model of ossification of the posterior longitudinal ligament of the spine (OPLL). Mamm Genome (1998) 0.93
Regulated expression of genes encoding soybean beta-conglycinins in transgenic plants. Dev Genet (1989) 0.93
Atrial fibrillation and embolic complications in paced patients. Pacing Clin Electrophysiol (1988) 0.93
[Alcohol and myocarditis]. Herz (1996) 0.92
Role of suppressor cells in the decline of natural killer cell activity in estrogen-treated mice. Cancer Res (1983) 0.92
Dispermic chimera associated with dysgerminoma. Exp Clin Immunogenet (1989) 0.92
Role of angiotensin II and prostaglandin E2 in regulating cardiac fibroblast collagen turnover. Am J Cardiol (1995) 0.91
[Seasonal variation of menarche and month of birth (author's transl)]. Arztl Jugendkd (1979) 0.91
Immunological cellular regulator and effector mechanisms in myocarditis. Herz (1985) 0.91
Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogenetics. Leukemia (1999) 0.91
A quantitative study of neurofibrillary tangles, senile plaques and astrocytes in the hippocampal subdivisions and entorhinal cortex in Alzheimer's disease, normal controls and non-Alzheimer neuropsychiatric diseases. Psychiatry Clin Neurosci (1998) 0.91
Apoptosis in myocarditis and dilated cardiomyopathy: does enterovirus genome persistence protect from apoptosis? An endomyocardial biopsy study. Cardiovasc Pathol (2001) 0.91
Regulation of the structural remodelling of the myocardium: from hypertrophy to heart failure. Eur Heart J (1994) 0.90
Cytokine activation in pericardial fluids in different forms of pericarditis. Herz (2000) 0.90